C vs REPL
Citigroup Inc. (C) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
REPL does not have a complete income-statement cache yet.
C currently screens at market cap $214.73B and trailing P/E 15.5. REPL currently screens at market cap $825.7M.
Not investment advice. Open the C and REPL stock pages for the full models.
Not investment advice.